Please enable JavaScript to continue using this application.

Compare $BOLD vs $INKT | Chartloom

Compare

$BOLD vs $INKT

Boundless Bio Inc · Mink Therapeutics Inc

BOLD

Boundless Bio Inc

INKT

Mink Therapeutics Inc

Compare $BOLD vs $INKT

Comparing Boundless Bio Inc and Mink Therapeutics Inc

BOLDBoundless Bio Inc

INKTMink Therapeutics Inc

BOLDBoundless Bio Inc

Market cap

$57M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

107.4%

52W performance

94.6%

FCF yield

-99.8%

INKTMink Therapeutics Inc

Market cap

$53M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-3.6%

52W performance

-26.5%

FCF yield

-12.8%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

BOLD

INKT

Detailed metrics comparison

BOLD

Boundless Bio Inc

INKT

Mink Therapeutics Inc

Market Cap

BOLD$57M

INKT$53M

Enterprise Value

BOLD$37M

INKT$45M

Price

BOLD$2.53

INKT$10.72

P/E Ratio

BOLDN/A

INKTN/A

P/S Ratio

BOLD0.00x

INKT0.00x

EV/Sales

BOLD0.00x

INKT0.00x

EV/EBITDA

BOLD0.00x

INKT0.00x

P/B Ratio

BOLD0.90x

INKT9.40x

P/FCF Ratio

BOLDN/A

INKTN/A

EV/FCF

BOLD-0.65x

INKT-6.53x

PEG Ratio

BOLDN/A

INKTN/A

Forward P/E (NTM)

BOLDN/A

INKTN/A

Forward P/S (NTM)

BOLDN/A

INKTN/A

Revenue (TTM)

BOLD$0

INKT$0

Revenue Growth (YoY)

BOLDN/A

INKTN/A

Forward Rev Growth

BOLD0.0%

INKT17.6%

Gross Margin (TTM)

BOLD0.0%

INKT0.0%

Operating Margin (TTM)

BOLD0.0%

INKT0.0%

EBITDA Margin (TTM)

BOLD0.0%

INKT0.0%

Net Margin (TTM)

BOLD0.0%

INKT0.0%

FCF Margin (TTM)

BOLDN/A

INKTN/A

Net Income (TTM)

BOLD$-64M

INKT$-11M

FCF (TTM)

BOLD$-57M

INKT$-7M

EPS (TTM)

BOLD-$2.85

INKT-$2.26

ROE (TTM)

BOLD-7089.0%

INKT-16887.0%

ROA (TTM)

BOLD-4737.0%

INKT-9237.0%

ROIC (TTM)

BOLD-7089.0%

INKT-16887.0%

Cash

BOLD$20M

INKT$9M

Debt

BOLD$0

INKT$0

Net Cash/Debt

BOLD$20M

INKT$9M

Current Ratio (TTM)

BOLD9.48x

INKT1.23x

Quick Ratio (TTM)

BOLD9.35x

INKT1.19x

Debt/Equity (TTM)

BOLD0.00x

INKT0.00x

Debt/Assets (TTM)

BOLD0.0%

INKT0.0%

Interest Coverage (TTM)

BOLDN/A

INKTN/A

Net Debt/EBITDA (TTM)

BOLD0.00x

INKT0.00x

Beta

BOLD0.44

INKT0.45

52W Performance

BOLD94.6%

INKT-26.5%

YTD Performance

BOLD107.4%

INKT-3.6%

% from 52W High

BOLD-20.0%

INKT-36.7%

% from 52W Low

BOLD163.2%

INKT26.4%

Asset Turnover (TTM)

BOLD0.00x

INKT0.00x

FCF Yield (TTM)

BOLD-99.8%

INKT-12.8%

Earnings Yield (TTM)

BOLD-112.6%

INKT-21.3%

Dividend Yield (TTM)

BOLDN/A

INKTN/A

Rule of 40

BOLD0.0

INKT0.0

EV/GP/RG

BOLDN/A

INKTN/A

Ticker research

View BOLD research View INKT research

Metric	BOLD Boundless Bio Inc	INKT Mink Therapeutics Inc
Market & Valuation
Market Cap	$57M	$53M
Enterprise Value	$37M	$45M
Price	$2.53	$10.72
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.90x	9.40x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.65x	-6.53x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	0.0%	17.6%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-64M	$-11M
FCF (TTM)	$-57M	$-7M
EPS (TTM)	-$2.85	-$2.26
ROE (TTM)	-7089.0%	-16887.0%
ROA (TTM)	-4737.0%	-9237.0%
ROIC (TTM)	-7089.0%	-16887.0%
Financial Health
Cash	$20M	$9M
Debt	$0	$0
Net Cash/Debt	$20M	$9M
Current Ratio (TTM)	9.48x	1.23x
Quick Ratio (TTM)	9.35x	1.19x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.44	0.45
52W Performance	94.6%	-26.5%
YTD Performance	107.4%	-3.6%
% from 52W High	-20.0%	-36.7%
% from 52W Low	163.2%	26.4%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-99.8%	-12.8%
Earnings Yield (TTM)	-112.6%	-21.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View BOLD research	View INKT research

Valuation

P/S Ratio

BOLD

0.00x

INKT

0.00x

EV/FCF

INKT

-6.53x

BOLD

-0.65x

Growth & revenue

Forward Revenue Growth

INKT

17.6%

BOLD

0.0%

Profitability & performance

Gross Margin

BOLD

0.0%

INKT

0.0%

ROE

BOLD

-7089.0%

INKT

-16887.0%

FCF Yield %

INKT

-12.8%

BOLD

-99.8%

52-Week Performance

BOLD

94.6%

INKT

-26.5%

Detailed metrics comparison

BOLD

Boundless Bio Inc

INKT

Mink Therapeutics Inc

Market Cap

BOLD$57M

INKT$53M

Enterprise Value

BOLD$37M

INKT$45M

Price

BOLD$2.53

INKT$10.72

P/E Ratio

BOLDN/A

INKTN/A

P/S Ratio

BOLD0.00x

INKT0.00x

EV/Sales

BOLD0.00x

INKT0.00x

EV/EBITDA

BOLD0.00x

INKT0.00x

P/B Ratio

BOLD0.90x

INKT9.40x

P/FCF Ratio

BOLDN/A

INKTN/A

EV/FCF

BOLD-0.65x

INKT-6.53x

PEG Ratio

BOLDN/A

INKTN/A

Forward P/E (NTM)

BOLDN/A

INKTN/A

Forward P/S (NTM)

BOLDN/A

INKTN/A

Revenue (TTM)

BOLD$0

INKT$0

Revenue Growth (YoY)

BOLDN/A

INKTN/A

Forward Rev Growth

BOLD0.0%

INKT17.6%

Gross Margin (TTM)

BOLD0.0%

INKT0.0%

Operating Margin (TTM)

BOLD0.0%

INKT0.0%

EBITDA Margin (TTM)

BOLD0.0%

INKT0.0%

Net Margin (TTM)

BOLD0.0%

INKT0.0%

FCF Margin (TTM)

BOLDN/A

INKTN/A

Net Income (TTM)

BOLD$-64M

INKT$-11M

FCF (TTM)

BOLD$-57M

INKT$-7M

EPS (TTM)

BOLD-$2.85

INKT-$2.26

ROE (TTM)

BOLD-7089.0%

INKT-16887.0%

ROA (TTM)

BOLD-4737.0%

INKT-9237.0%

ROIC (TTM)

BOLD-7089.0%

INKT-16887.0%

Cash

BOLD$20M

INKT$9M

Debt

BOLD$0

INKT$0

Net Cash/Debt

BOLD$20M

INKT$9M

Current Ratio (TTM)

BOLD9.48x

INKT1.23x

Quick Ratio (TTM)

BOLD9.35x

INKT1.19x

Debt/Equity (TTM)

BOLD0.00x

INKT0.00x

Debt/Assets (TTM)

BOLD0.0%

INKT0.0%

Interest Coverage (TTM)

BOLDN/A

INKTN/A

Net Debt/EBITDA (TTM)

BOLD0.00x

INKT0.00x

Beta

BOLD0.44

INKT0.45

52W Performance

BOLD94.6%

INKT-26.5%

YTD Performance

BOLD107.4%

INKT-3.6%

% from 52W High

BOLD-20.0%

INKT-36.7%

% from 52W Low

BOLD163.2%

INKT26.4%

Asset Turnover (TTM)

BOLD0.00x

INKT0.00x

FCF Yield (TTM)

BOLD-99.8%

INKT-12.8%

Earnings Yield (TTM)

BOLD-112.6%

INKT-21.3%

Dividend Yield (TTM)

BOLDN/A

INKTN/A

Rule of 40

BOLD0.0

INKT0.0

EV/GP/RG

BOLDN/A

INKTN/A

Ticker research

View BOLD research View INKT research

Metric	BOLD Boundless Bio Inc	INKT Mink Therapeutics Inc
Market & Valuation
Market Cap	$57M	$53M
Enterprise Value	$37M	$45M
Price	$2.53	$10.72
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.90x	9.40x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.65x	-6.53x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	0.0%	17.6%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-64M	$-11M
FCF (TTM)	$-57M	$-7M
EPS (TTM)	-$2.85	-$2.26
ROE (TTM)	-7089.0%	-16887.0%
ROA (TTM)	-4737.0%	-9237.0%
ROIC (TTM)	-7089.0%	-16887.0%
Financial Health
Cash	$20M	$9M
Debt	$0	$0
Net Cash/Debt	$20M	$9M
Current Ratio (TTM)	9.48x	1.23x
Quick Ratio (TTM)	9.35x	1.19x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.44	0.45
52W Performance	94.6%	-26.5%
YTD Performance	107.4%	-3.6%
% from 52W High	-20.0%	-36.7%
% from 52W Low	163.2%	26.4%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-99.8%	-12.8%
Earnings Yield (TTM)	-112.6%	-21.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View BOLD research	View INKT research